Neuropsychological Outcome After Cardiac Arrest
1 other identifier
observational
200
3 countries
8
Brief Summary
This study is a sub-study to the large pragmatic Target Temperature Management 2 Trial (TTM2-trial, ClinicalTrials.gov Identifier: NCT02908308), assessing effectiveness of controlled hypothermia after out-of-hospital cardiac arrest (OHCA). This study is designed to provide detailed information on cognition after OHCA and its relationship to associated factors as emotional function, fatigue, and sleep. A secondary aim is to utilize this information to validate a neurocognitive screening battery used 6 months after OHCA in the TTM2-trial. Approximately 7 and 24 months after OHCA, survivors at selected TTM2 study sites will perform a standardized neuropsychological assessment including performance-based tests of cognition and questionnaires of behavioral and emotional function, fatigue, and insomnia. At 1:1 ratio, a control group of myocardial infarction (MI) patients but no occurrence of cardiac arrest will be recruited and perform the same test battery. Group differences at 7 and 24 months will be analyzed per cognitive domain (verbal, visual/constructive, short-term working memory, episodic memory, processing speed, executive functions). Results of the OHCA survivors on the TTM2 neurocognitive screening battery will be compared with neuropsychological test results at 7 months time.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2018
Longer than P75 for all trials
8 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 17, 2018
CompletedFirst Posted
Study publicly available on registry
June 1, 2018
CompletedStudy Start
First participant enrolled
July 13, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 11, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 23, 2022
CompletedDecember 19, 2025
September 1, 2023
2.5 years
May 17, 2018
December 12, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cognitive impairment
Cognitive function in OHCA and MI patients, using composite z-scores from the neuropsychological tests grouped by cognitive domain.
7 months after the cardiac event
Secondary Outcomes (1)
Sensitivity and specificity of the neurocognitive screening battery in the main TTM2-trial
7 months post-arrest
Other Outcomes (1)
Change in cognitive function
7 months, 24 months after the cardiac event
Study Arms (2)
Cardiac Arrest survivors
Cardiac arrest survivors at selected TTM2-sites only.
Myocardial Infarction patients
A control group from a cohort of patients with myocardial infarction with performed coronary angiography but no occurrence of cardiac arrest will be recruited at 1:1 ratio.
Interventions
Standardized neuropsychological battery consisting of the following tests and questionnaires: Wechsler Adult Intelligence Scale - Fourth Edition (WAIS-IV) Vocabulary, Delis-Kaplan Executive Function System (D-KEFS) Verbal Fluency, WAIS-IV Block Design, WAIS-IV Matrix Reasoning, WAIS-IV Digit Span, Wechsler Memory Scale - Third Edition (WMS-III) Spatial Span, Rey Auditory Verbal Learning Test (RAVLT), WMS-III Logical Memory, Brief Visuospatial Memory Test-Revised (BVMT-R), Trail Making Test (TMT) A \& B, D-KEFS Color Word Interference Test, Behavioral Assessment of the Dysexecutive Syndrome Dysexecutive Questionnaire (BADS DEX), Multidimensional Fatigue Inventory (MFI-20), Minimal Insomnia Symptom Scale (MISS), Hospital Anxiety and Depression Scale (HADS).
Eligibility Criteria
OHCA survivors at TTM2-sites participating in this study. Survivors are invited to partake in this study at the regular six-month follow-up of the TTM2-trial. The cohort of MI patients acting as controls are recruited and assessed at one participating site per country through quality registers.
You may qualify if:
- OHCA of a presumed cardiac or unknown cause (OHCA cohort only)
- Sustained return of spontaneous circulation (ROSC) during intensive care - defined as 20 minutes with signs of circulation without the need for chest compressions (OHCA cohort only)
- Unconsciousness - defined as not being able to obey verbal commands (FOUR-score motor response of \<4) and no verbal response to pain after sustained ROSC (OHCA cohort only)
- During intensive care - eligible for intensive care without restrictions or limitations (OHCA cohort only)
- MI with performed coronary angiography (MI cohort only)
You may not qualify if:
- Temperature on admission \<30°C (OHCA cohort only)
- On extracorporeal membrane oxygenation (ECMO) prior to return of spontaneous circulation (OHCA cohort only)
- Obvious or suspected pregnancy
- Intracranial bleeding (OHCA cohort only)
- Severe chronic obstructive pulmonary disorder (COPD) with long-term home oxygen therapy
- Clinical dementia diagnosis before the event
- Inability to speak the local language well enough to complete the assessment without assistance from an interpreter
- Inability to meet for a face-to-face examination
- Clinical Frailty Scale Index ≥8, indicating very severe frailty
- Cardiac arrest before or in connection with MI (MI cohort only)
- Active substance abuse
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Region Skanelead
- Lund Universitycollaborator
- Halmstad County Hospitalcollaborator
- Sahlgrenska University Hospitalcollaborator
- Mid and South Essex NHS Foundation Trustcollaborator
- Cardiff and Vale University Health Boardcollaborator
- Aarhus University Hospitalcollaborator
Study Sites (8)
Aarhus University Hospital
Aarhus, Denmark
Sahlgrenska University Hospital
Gothenburg, Sweden
Halmstad County Hospital
Halmstad, Sweden
Helsingborg Hospital
Helsingborg, Sweden
Skane University Hospital
Lund, Sweden
Skane University Hospital
Malmo, Sweden
The Essex Cardiothoracic Centre, Basildon and Thurrock University Hospitals NHS Foundation Trust
Basildon, Essex, United Kingdom
University Hospital of Wales, Cardiff and Vale University Health Board
Cardiff, Wales, United Kingdom
Related Publications (4)
Blennow Nordstrom E, Lilja G, Vestberg S, Ullen S, Friberg H, Nielsen N, Heimburg K, Evald L, Mion M, Segerstrom M, Grejs AM, Keeble T, Kirkegaard H, Ljung H, Rose S, Wise MP, Rylander C, Unden J, Cronberg T. Neuropsychological outcome after cardiac arrest: a prospective case control sub-study of the Targeted hypothermia versus targeted normothermia after out-of-hospital cardiac arrest trial (TTM2). BMC Cardiovasc Disord. 2020 Oct 7;20(1):439. doi: 10.1186/s12872-020-01721-9.
PMID: 33028221BACKGROUNDBlennow Nordstrom E, Evald L, Mion M, Segerstrom M, Vestberg S, Ullen S, Heimburg K, Gregersen Oestergaard L, Grejs AM, Keeble TR, Kirkegaard H, Rylander C, Wise MP, Lilja G. Combined use of the Montreal Cognitive Assessment and Symbol Digit Modalities Test improves neurocognitive screening accuracy after cardiac arrest: A validation sub-study of the TTM2 trial. Resuscitation. 2024 Sep;202:110361. doi: 10.1016/j.resuscitation.2024.110361. Epub 2024 Aug 13.
PMID: 39147306RESULTVig A, Vestberg S, Evald L, Mion M, Segerstrom M, Ullen S, Arestedt K, Nielsen N, Cronberg T, Lilja G, Blennow Nordstrom E. Psychometric properties of the Dysexecutive Questionnaire (DEX) in individuals with a previous cardiac event. Neuropsychol Rehabil. 2025 Nov 27:1-21. doi: 10.1080/09602011.2025.2591784. Online ahead of print.
PMID: 41308659RESULTBlennow Nordstrom E, Vestberg S, Evald L, Mion M, Segerstrom M, Ullen S, Bro-Jeppesen J, Friberg H, Heimburg K, Grejs AM, Keeble TR, Kirkegaard H, Ljung H, Rose S, Wise MP, Rylander C, Unden J, Nielsen N, Cronberg T, Lilja G. Neuropsychological outcome after cardiac arrest: results from a sub-study of the targeted hypothermia versus targeted normothermia after out-of-hospital cardiac arrest (TTM2) trial. Crit Care. 2023 Aug 26;27(1):328. doi: 10.1186/s13054-023-04617-0.
PMID: 37633944RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Niklas Nielsen, MD, PhD
Lund University
- STUDY DIRECTOR
Gisela Lilja, PhD, OT
Lund University
- STUDY DIRECTOR
Tobias Cronberg, MD, PhD
Lund University
- STUDY DIRECTOR
Susanna Vestberg, PhD, Lic.Psych.
Lund University
- PRINCIPAL INVESTIGATOR
Erik Blennow Nordström, PhD, Lic.Psych.
Lund University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 17, 2018
First Posted
June 1, 2018
Study Start
July 13, 2018
Primary Completion
January 11, 2021
Study Completion
May 23, 2022
Last Updated
December 19, 2025
Record last verified: 2023-09